[Synacthen-depot treatment during withdrawal of long-term corticotherapy in patients with asthma].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000138:chemical synthesis / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone
Zastosowanie preparatu Synacthen-depot w wyłaczaniu przewlekłej kortykoterapii u chorych z dychawica oskrzelowa.